Peixuan Guo is the Director of the NIH Nanomedicine Development Center at the University of Cincinnati, Ohio and the Director of the NIH/NCI Cancer Nanotechnology Platform Partnership Program: RNA Nanotechnology for Cancer Therapy at Purdue University, Indiana. He is also a Fellow of the National Academy of Inventors. Aibing Wang is a Molecular Biologist in Department of Oncology, Lombardi Comprehensive cancer center, Georgetown University Medical Center and a chemist in SynerGene Therapeutics, Inc. (SGT).